FASN has been shown to be highly expressed in the drug-resistant BC cell line MCF7/AdVp3000, increasing palmitate content, which modulates the transverse mobility of membrane components and disrupts DOX uptake [80]. The gene discussed is FASN; the disease is breast cancer.